Boyle Scott N

Insider profile

Boyle Scott N's trades of C4 Therapeutics, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
431.53
Quantity 33,942 +29.8%
Value US$1,447,231
Transaction date
Planned sale
Price
82.94
Quantity 75,116 +5.2%
Value US$1,523,572
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-18 2025-02-18 PlS Planned sale
33,942 +29.8%
431.53
US$1,447,231
33,942 +29.8% 431.53 US$1,447,231
2025-02-18 2025-02-14 PlS Planned sale
75,116 +5.2%
82.94
US$1,523,572
75,116 +5.2% 82.94 US$1,523,572